Treatment of xanthelasma palpebrarum with a 1064-nm, Q-switched Nd:YAG laser

Xanthelasma palpebrarum is the most common cutaneous xanthoma characterized by soft, yellow papules or plaques that arise on the periorbital skin. As these lesions can be cosmetically disfiguring, many patients seek medical help to remove these lesions. To determine the effectiveness and minimum num...

Full description

Saved in:
Bibliographic Details
Published inJournal of the American Academy of Dermatology Vol. 77; no. 4; pp. 728 - 734
Main Authors Heng, Jun Khee, Chua, Sze Hon, Goh, Chee Leok, Cheng, Suzanne, Tan, Virlynn, Tan, Wee Ping
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.10.2017
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Xanthelasma palpebrarum is the most common cutaneous xanthoma characterized by soft, yellow papules or plaques that arise on the periorbital skin. As these lesions can be cosmetically disfiguring, many patients seek medical help to remove these lesions. To determine the effectiveness and minimum number of treatment sessions with a 1064-nm, Q-switched neodymium-doped yttrium aluminum garnet (Nd:YAG) laser for the treatment of xanthelasma. A retrospective review of patients with xanthelasma consecutively treated with Q-switched Nd:YAG laser was conducted. Forty-six patients with 103 lesions were identified from January 2012 through August 2015. Photographs taken of patients immediately before treatment and 4-8 weeks after treatment were independently evaluated by 2 dermatologists. After a single treatment session, 93.2% of lesions had some degree of clearance. All lesions had excellent-to-complete clearance after at least 4 treatment sessions. Patients usually required 4 treatment sessions for optimal results. This was a retrospective study. Treatment parameters varied, follow-up periods were not uniform, and response was not assessed with a validated scale. The Q-switched Nd:YAG laser is effective and well tolerated in the treatment of xanthelasma in our study population.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0190-9622
1097-6787
DOI:10.1016/j.jaad.2017.03.041